All Stories

  1. Acetylated Signal Transducer and Activator of Transcription 3 Functions as Molecular Adaptor Independent of Transcriptional Activity during Human Cardiogenesis
  2. Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model
  3. ErbB Receptor Tyrosine Kinase: A Molecular Switch Between Cardiac and Neuroectoderm Specification in Human Pluripotent Stem Cells
  4. Phasic modulation of Wnt signaling enhances cardiac differentiation in human pluripotent stem cells by recapitulating developmental ontogeny
  5. A Systemic Evaluation of Cardiac Differentiation from mRNA Reprogrammed Human Induced Pluripotent Stem Cells
  6. Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes
  7. Critical path in cardiac stem cell therapy: an update on cell delivery
  8. Arsenic induced neuronal apoptosis in guinea pigs is Ca2+ dependent and abrogated by chelation therapy: Role of voltage gated calcium channels
  9. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart
  10. Cardiac Stem Cell Therapy: Stemness or Commitment?
  11. Pharmacoelectrophysiology of Viral-Free Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes
  12. MiADMSA reverses impaired mitochondrial energy metabolism and neuronal apoptotic cell death after arsenic exposure in rats
  13. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells
  14. G-CSF administration in acute myocardial infarction: what is the best timing? Reply
  15. Molecular and cellular characterization of expanded and cryopreserved human limbal epithelial stem cells reveal unique immunological properties
  16. Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines
  17. G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?
  18. Monoisoamyl dimercaptosuccinic acid abrogates arsenic-induced developmental toxicity in human embryonic stem cell-derived embryoid bodies: Comparison with in vivo studies
  19. Arsenic moiety in gallium arsenide is responsible for neuronal apoptosis and behavioral alterations in rats
  20. Combinational chelation therapy abrogates lead-induced neurodegeneration in rats
  21. Prevention of arsenic-induced hepatic apoptosis by concomitant administration of garlic extracts in mice
  22. Assessment of drug induced developmental toxicity using human embryonic stem cells
  23. Reversal of Arsenic-Induced Hepatic Apoptosis with Combined Administration of DMSA and Its Analogues in Guinea Pigs: Role of Glutathione and Linked Enzymes
  24. 8-Methly-4-(3-diethylaminopropylamino) pyrimido [4′,5′;4,5] thieno (2,3–b) quinoline (MDPTQ), a quinoline derivate that causes ROS-mediated apoptosis in leukemia cell lines
  25. Reversal of Lead-Induced Neuronal Apoptosis by Chelation Treatment in Rats: Role of Reactive Oxygen Species and Intracellular Ca2+
  26. Mechanism of metalloid-induced death in Leishmania spp.: Role of iron, reactive oxygen species, Ca2+, and glutathione
  27. Monoisoamyl dimercaptosuccinic acid induced changes in pregnant female rats during late gestation and lactation
  28. Therapeutic potential of monoisoamyl and monomethyl esters of meso 2,3-dimercaptosuccinic acid in gallium arsenide intoxicated rats
  29. Apoptotic Death in Leishmania donovani Promastigotes in Response to Respiratory Chain Inhibition: COMPLEX II INHIBITION RESULTS IN INCREASED PENTAMIDINE CYTOTOXICITY
  30. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication
  31. Aluminum-induced oxidative stress in rat brain: response to combined administration of citric acid and HEDTA
  32. Haematological, hepatic and renal alterations after repeated oral and intraperitoneal administration of monoisoamyl DMSA. II. Changes in female rats
  33. Haematological, hepatic and renal alterations after repeated oral or intraperitoneal administration of monoisoamyl DMSA. I. Changes in male rats
  34. Possible role of metal redistribution, hepatotoxicity and oxidative stress in chelating agents induced hepatic and renal metallothionein in rats
  35. Combined administration of a chelating agent and an antioxidant in the prevention and treatment of acute lead intoxication in rats